Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Comparison of Combination Therapy (Thalidomide and Hydroxyurea) vs Thalidomide Alone in Beta Thalassemia.

NCT06490601 is registered in ClinicalTrials.gov with National Institute of Blood and Marrow Transplant (NIBMT), Pakistan as lead sponsor.

NCT NCT06490601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06490601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Comparison of Combination Therapy (Thalidomide and Hydroxyurea) vs Thalidomide Alone in Beta Thalassemia.
Lead sponsor
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 1, 2022
Completion date
July 1, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

beta-thalassemia, fetal hemoglobin, hemoglobinopathies